Clinical Trial: A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
Sponsor and CollaboratorsUniversity of Pittsburgh
National Cancer Institute (NCI)
ContactContact: Athanassios Argiris, MD
(412) 623-4083
argirisae@upmc.edu
Contact: Rita Johnson, RN
(412) 547-5871
johnsonr1@upmc.edu
Principal InvestigatorAthanassios Argiris, MD ECOG
ClinicalTrials.gov IdentifierNCT00409565